Paper Review Records
All Paper Review Records
11 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
74
days
The endothelial cell–neutrophil axis: Mechanisms and therapeutic perspectives in colitis-associated carcinogenesis
Authors
Peng Cheng; Ying Huang; Ruoxuan Xiao; Yixiang Luo; Yueying Huang; Hongkuan Han; Yang Shen; Cheng Qian; Lei Chen; Yang ZhaoShow moreShow less
Affiliations
Drum Tower Hospital Clinical College, Nanjing Drum Tower Hospital, Nanjing University of Chinese Medicine, Nanjing 210023, China; School of Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China; School of Life Science and Technology, Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing 210031, China; Institute of Translational Medicine, School of Medicine, Zhejiang University, Hangzhou 310029, China; Institute of Microphysiological Systems, Southeast University, Nanjing 211189, ChinaShow moreShow less
95
days
Enhancing immune checkpoint blockade therapy of genitourinary malignancies by co-targeting PMN-MDSCs
Authors
Xuemin Lu; Xin LuShow moreShow less
Affiliations
Department of Biological Sciences, Boler-Parseghian Center for Rare and Neglected Diseases, Harper Cancer Research Institute, University of Notre Dame, Notre Dame, IN 46556, USA; Tumor Microenvironment and Metastasis Program, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN 46202, USAShow moreShow less
75
days
The case for AI-driven cancer clinical trials – The efficacy arm in silico
Authors
Likhitha Kolla; Fred K. Gruber; Omar Khalid; Colin Hill; Ravi B. ParikhShow moreShow less
Affiliations
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; GNS Healthcare, Somerville, MA, USAShow moreShow less
77
days
The potential of AI in cancer care and research
Authors
Norman E. Sharpless; Anthony R. KerlavageShow moreShow less
Affiliations
National Cancer Institute, Bethesda, MD, United States of AmericaShow moreShow less
85
days
Data-driven approaches to advance research and clinical care for pediatric cancer
Authors
Alexander M. Gout; Sasi Arunachalam; David B. Finkelstein; Jinghui ZhangShow moreShow less
Affiliations
Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USAShow moreShow less
27
days
Pediatric low-grade gliomas: How modern biology reshapes the clinical field
Authors
Guillaume Bergthold; Pratiti Bandopadhayay; Wenya Linda Bi; Lori Ramkissoon; Charles Stiles; Rosalind A. Segal; Rameen Beroukhim; Keith L. Ligon; Jacques Grill; Mark W. KieranShow moreShow less
Affiliations
Department of Cancer Biology, Dana–Farber Cancer Institute, Boston, MA, USA; Departement de Cancerologie de l'enfant et de l'adolescent, Gustave Roussy and Unité Mixte de Recherche 8203 du Centre National de la Recherche Scientifique, Université Paris-Sud, Villejuif, France; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA; Center for Molecular Oncologic Pathology, Dana–Farber Cancer Institute, Boston, MA, USA; Division of Pediatric Hematology and Oncology, Dana–Farber Cancer Institute, Boston, MA, USA; Boston Children's Hospital, Boston, MA, USA; Department of Neurobiology, Harvard Medical School, Boston, MA, USAShow moreShow less
FAQ
How long does BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER take to review a manuscript?
As of 2026-11-19, CrushSCI has 11 complete review records for BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. The fastest paper went from submission to acceptance in 27 days (Pediatric low-grade gliomas: How modern biology reshapes the clinical field, received 2014-01-24, accepted 2014-02-20); the slowest took 118 days. The average is 73.3 days and the median is 77 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
